WATCH LIVE
timothy sykes logo
AGL Jumps As agilon health Steps Up Conference Push Thumbnail
G Google News

AGL Jumps As agilon health Steps Up Conference Push

TIM SYKES•UPDATED JUN. 26, 2026, 4:08 PM ET
Reviewed by Bryce Tuoheyand Fact-checked by Matt Monaco

Agilon health inc. stocks have been trading up by 10.11 percent amid optimism over expanded value-based primary care partnerships.

What Traders Need To Know

  • Management will present at two healthcare and digital health conferences, using panels and one-on-ones to clarify agilon health’s value-based care model for institutions watching AGL.
  • Conference activity is aimed at deeper industry visibility and engagement, not at changing revenue guidance or near-term fundamentals.
  • Multiple insider Form 4 filings show changes in AGL beneficial ownership, but with no detail on size, price, or buy vs. sell, they offer weak directional edge.
  • Recent price action shows a sharp rebound toward $114 after a pullback near $107, signaling aggressive dip demand intraday.

Candlestick Chart

Weekly Update Jun 22 – Jun 26, 2026: On Friday, June 26, 2026 agilon health inc. stock [NYSE: AGL] is trending up by 10.11%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – positive

agilon health (AGL) remains a scale player in senior-focused, value-based primary care, with revenue growing 28–34% over three to five years and strong asset turnover of 3.4x, but profitability is poor: EBIT margin is –6.3% and ROE/ROA are deeply negative. Nonetheless, Q1 2026 shows an inflection: positive net income of $49 million, EBITDA of $38.5 million, and free cash flow of $20.6 million, supported by modest leverage (debt/equity 0.17, current ratio ~1.0).

Technically, AGL has been volatile but biased higher this week: the stock rebounded from 106.80–107.25 support to close at 114 after spiking to 119.25. The 5‑minute tape shows heavy volume and rejection above 118–119, confirming that zone as near-term resistance. The dominant short-term trend is up from the low 100s, but extended. Actionable level: buy pullbacks toward 107–110 with a tight stop below 106.50, targeting a retest of 118–120.

Near-term news flow is light but constructive: management’s participation in healthcare and digital health conferences supports the narrative around ACOs and value-based care, important vs. Healthcare Providers & Services peers trading on scalable, capitated models. Sector benchmarks generally show mid-single-digit margins; AGL’s improving but still negative margin makes it a higher-risk, higher-growth name. I expect continued operating leverage and multiple expansion, with technical support at 106–107, resistance at 118–120, and a 6–12 month upside target of $125.

More Breaking News

Quick Financial Overview

AGL (agilon health inc.) is trading in a tight but active range on the weekly tape. The stock dipped from about $113 to a low near $107, then reversed and closed the latest bar around $114. That swing shows real two-way action, but with buyers stepping in quickly under $110. For short-term traders, that $106–$108 zone now stands out as the first key support band on the higher timeframe.

On the intraday chart, AGL opened soft near $106–$108, then built a steady trend higher through midday before spiking in the afternoon. The push from roughly $108 at mid-session to a late high near $119.25, before settling back to $114, is classic momentum followed by profit taking. Volume is not provided, but the smooth stair-step price pattern suggests controlled buying rather than a one-off news spike.

Fundamentals for agilon health inc. are mixed. Revenue is strong at about $5.93B with solid multi-year growth, but margins are still negative, with profit margins around -6%. Returns on equity and assets are also negative, reflecting a business still in scale-up and optimization mode. Low price-to-sales near 0.08 and manageable debt-to-equity around 0.17 point to some balance-sheet support, yet traders must remember this is not a clean, high-margin story.

Conclusion

AGL sits at an interesting crossroads where price action looks constructive, but the news flow and financial profile argue for disciplined risk management. The recent rally from the $107 area back toward $114–$119 shows buyers willing to defend dips, likely as traders position ahead of more clarity on agilon health inc.’s value-based care growth path. At the same time, the main corporate update is management’s conference participation, which is more about storytelling and visibility than immediate earnings change.

The run of Form 4 filings adds noise but not much signal, because there is no data on whether insiders are net buying or selling, or at what size. For short-term traders, the cleaner edge is on the chart: $106–$108 as near-term support, the $119 intraday high as local resistance, and the broader trend defined by whether AGL can hold higher lows above $110. agilon health inc. still carries negative margins and weak returns, so any long bias should be paired with tight risk controls and clear exit plans. As millionaire penny stock trader and teacher Tim Sykes, says, “You must adapt to the market; the market will not adapt to you.”, and that mindset is especially relevant here as traders react to shifting price levels against a backdrop of mixed fundamentals.

As I tell my students, “Price is your truth, news is your context — when a stock like AGL is grinding higher on mixed fundamentals, you trade the levels, not the story.”

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”